Navigation Links
UC Davis bench-to-bedside research: Promising treatment in clinical trials
Date:3/26/2009

Hammock faced two major obstacles: financing and moving the drug into clinical trials.

"Finding resources in an academic laboratory to move a first-in-class drug through clinical trials, is difficult," Hammock said. "It costs $700 million to $1.2 billion to get a treatment to the market."

"Publicly funded research," the professor said, "results in many new possible pharmaceutical targets that could be exploited by either small molecule drugs or biotechnology. However, society faces a serious problem in that few of these leads are followed and there is a widely held view that universities cannot validate a target, much less optimize a pharmaceutical."

So in 2002, Hammock founded the biotech company, Arte Therapeutics, Inc., naming the company a mountaineering term that means "sharp, steep ridge." Specifically, the company is named for the artes of the Bear Creek Spire of the Sierra Nevada that he, his sons and occasionally other UC Davis faculty and students climb.

"The artes that climbers follow to peaks are often inspiring as well as challenging," Hammock said. "I founded the company because I failed to transfer technology to the public from the University of California by other means in the past," Hammock said. "And I received nothing more than a passing interest from pharmaceutical companies at that time, but now they are very interested."

In 2003, he and his son, also named Bruce, incorporated the company to move the materials into clinical trials. "To get funding we had to make a case for a new drug when current therapy was thought to be adequate," the professor said. "There are few good drugs for end organ failure and vascular inflammation." Vascular inflammation is involved in diabetes and obesity side effects.

"The collaborative and interdisciplinary environment at UC Davis permitted us, with support from the National Institute of Environmental Health Sciences, to optimize the potency and drug
'/>"/>

Contact: Kathy Keatley Garvey
kegarvey@ucdavis.edu
530-754-6894
University of California - Davis
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. UC Davis research shows that newly discovered drug reduces heart enlargement
2. UC Davis researchers find molecule that targets brain tumors
3. UC Davis discovery offers hope for treating kidney cancer
4. UC Davis team refines cancer treatments to reduce potential nerve damage
5. UC Davis researchers exploring gene therapy to fight AIDS
6. UC Davis researchers discover Achilles heel in pancreatic cancer
7. UC Davis researchers discover a key to aggressive breast cancer
8. UC Davis chemical ecologist wins major award
9. UC Davis researchers discover new drug target for inflammatory disease
10. UC Davis researchers define characteristics, treatment options for XXYY syndrome
11. UC Davis researcher leads climate-change discovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC Davis bench-to-bedside research: Promising treatment in clinical trials
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, Inc. ... and security systems is pleased to announce that Dr ... a consultant and member of its scientific advisory board. ... known as a thought leader in technology-enhanced learning models. ... Group, and has published studies and books focused on ...
(Date:4/17/2015)... , April 17, 2015 ... security concerns, and technological advancement to drive biometric ... until 2020   According to ... Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market ... projected to register growth at CAGR of over ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... Solomons, Md. (September 21, 2010) In ... new research led by a team of University of ... a new, stakeholder-driven process can improve the way we ... In the September issue of the journal ...
... for Cancer Research will host its Fourth AACR International ... Sept. 27-30, 2010, at the Sheraton Denver Downtown in ... imaging and other new technologies are leading to a ... a more precise understanding of a patient,s tumor and ...
... This release is available in Spanish . ... a new therapy for the treatment of skin and lung cancer. ... that can induce death to cells transfected with it.. Their studies ... (using tumour cell cultures), but also in vivo through the use ...
Cached Biology News:New collaborative process can help improve management of marine recreational fisheries 2The AACR to host molecular diagnostics conference 2New therapy found for lung and skin cancer, based on suicide gene E 2
(Date:5/21/2015)... As part of its philanthropic partnership with Banner ... funded a $3.25 million project to relocate and equip ... up-to-date features and technology. , The new pharmacy is ... members will begin moving from the current location to ... , The current pharmacy has been using a ...
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
(Date:5/20/2015)... global genotyping market is expected to grow at a ... to 2020 to reach $17.0billion in 2020. Genotyping tests ... process and to provide personalized therapy, factors that are ... key manufacturers to offer advanced and innovative products for ... market data tables & 37 figures spread through 200 ...
(Date:5/20/2015)... , May 20, 2015  Cypher Genomics, ... a collaboration with Celgene Corporation to apply Cypher,s ... biomarkers that associate with patient response to innovative ... intended to help accelerate patient access to the ... in clinical research and development and potentially inform ...
Breaking Biology Technology:Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2
... Ariz., June 28, 2011 The PleuraFlow™ Active Tube Clearance™ ... the 49th Annual R&D 100 Awards, which salute the 100 ... past year. A full list of this year,s winners is ... heels of winning a 2011 MDEA Gold award, as well ...
... June 28, 2011 Intarcia Therapeutics, Inc. announced ... a phase 2 clinical study of ITCA 650 ... treatment of type 2 diabetes at the American ... California. (Logo:   http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO ) ...
... Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing ... with the investment community tomorrow, Wednesday, June 29, ... Company,s Chairman and Chief Executive Officer, Anthony J. ... and discuss the clinical and commercial development plans ...
Cached Biology Technology:PleuraFlow Captures Prestigious Innovation Award 2PleuraFlow Captures Prestigious Innovation Award 3PleuraFlow Captures Prestigious Innovation Award 4Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions 2Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions 3Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions 4Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions 5Genesis Biopharma Conference Call and Webcast Reminder 2
Sulfadimethoxine (CH-2027)...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Bovine Endometrium Epithelial Cells (BEnEpC) (>500,000 cells)...
... The EC3 Darkroom is designed for imaging ... The EC3 systems offer direct control for ... darkroom settings by hand , A range ... best system for all fluorescent and chemiluminescent ...
Biology Products: